Use of multiparametric magnetic resonance imaging (mpMRI) in localized prostate cancer

References

• Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer. 2008;8(4):268–278.
   PubMed Web of Science ®Google Scholar
• Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981–990.
   PubMed Web of Science ®Google Scholar
• Telesca D, Etzioni R, Gulati R. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Biometrics. 2008;64(1):10–19.
   PubMed Web of Science ®Google Scholar
• Schulte RT, Wood DP, Daignault S, et al. Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy. Cancer. 2008;113(7):1559–1565.
   PubMed Web of Science ®Google Scholar
• Mayes JM, Mouraviev V, Sun L, et al. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol. 2011;29(2):166–170.
   PubMed Web of Science ®Google Scholar
• Nam RK, Wallis CJ, Stojcic-Bendavid J, et al. A pilot study to evaluate the role of magnetic resonance imaging for prostate cancer screening in the general population. J Urol. 2016;196(2):361–366.
   PubMed Web of Science ®Google Scholar
• Bjurlin MA, Carroll PR, Eggener S, et al. Update of the AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. J Urol. 2020 Apr;203(4):706–712.
   PubMed Web of Science ®Google Scholar
• Rastinehad AR, Baccala AA Jr., Chung PH, et al. D’Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol. 2011;185(3):815–820.
   PubMed Web of Science ®Google Scholar
• Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–822.
   PubMed Web of Science ®Google Scholar
• Mehralivand S, Shih JH, Rais-Bahrami S, et al. A magnetic resonance imaging-based prediction model for prostate biopsy risk stratification. JAMA Oncol. 2018;4(5):678–685.
   PubMed Web of Science ®Google Scholar
• Siddiqui MM, Rais-Bahrami S, Turkbey B, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. Jama. 2015;313(4):390–397.
   PubMed Web of Science ®Google Scholar
• Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol. 2016;69(1):16–40.
   PubMed Web of Science ®Google Scholar
• Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378(19):1767–1777.
   PubMed Web of Science ®Google Scholar
• Lebastchi AH, Pinto PA. The role of multiparametric MRI in biopsy-naive prostate cancer. Nat Rev Urol. 2019;16(5):276–277.
   PubMed Web of Science ®Google Scholar
• Rouviere O, Puech P, Renard-Penna R, et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20(1):100–109.
   PubMed Web of Science ®Google Scholar
• van der Leest M, Cornel E, Israel B, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naive men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol. 2019;75(4):570–578.
   PubMed Web of Science ®Google Scholar
• Drost FH, Osses DF, Nieboer D, et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019;4:Cd012663.
   PubMedGoogle Scholar
• Davis KM, Kelly SP, Luta G, et al. The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors. Urology. 2014;84(2):300–306.
   PubMed Web of Science ®Google Scholar
• Moore CM, Giganti F, Albertsen P, et al. Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force. Eur Urol. 2017;71(4):648–655.
   PubMed Web of Science ®Google Scholar
• Klotz L, Loblaw A, Sugar L, et al. Active surveillance magnetic resonance imaging study (ASIST): results of a randomized multicenter prospective trial. Eur Urol. 2019;75(2):300–309.
   PubMed Web of Science ®Google Scholar
• Klotz L, Pond G, Loblaw A, et al. Randomized study of systematic biopsy versus magnetic resonance imaging and targeted and systematic biopsy in men on active surveillance (ASIST): 2-year postbiopsy follow-up. Eur Urol. 2020 Mar;77(3):311–317.
   PubMed Web of Science ®Google Scholar
• Wysock JS, Lepor H. Multi-parametric MRI imaging of the prostate-implications for focal therapy. Transl Androl Urol. 2017;6(3):453–463.
   PubMed Web of Science ®Google Scholar
• Marenco J, Orczyk C, Collins T, et al. Role of MRI in planning radical prostatectomy: what is the added value? World J Urol. 2019;37(7):1289–1292.
   PubMed Web of Science ®Google Scholar
• Rayn KN, Bloom JB, Gold SA, et al. Added value of multiparametric magnetic resonance imaging to clinical nomograms for predicting adverse pathology in prostate cancer. J Urol. 2018;200(5):1041–1047.
   PubMed Web of Science ®Google Scholar
• Mungovan SF, Sandhu JS, Akin O, et al. Preoperative membranous urethral length measurement and continence recovery following radical prostatectomy: a systematic review and meta-analysis. Eur Urol. 2017;71(3):368–378.
   PubMed Web of Science ®Google Scholar
• Schiavina R, Bianchi L, Borghesi M, et al. MRI displays the prostatic cancer anatomy and improves the bundles management before robot-assisted radical prostatectomy. J Endourol. 2018;32(4):315–321.
   PubMed Web of Science ®Google Scholar
• Panebianco V, Barchetti G, Simone G, et al. Negative multiparametric magnetic resonance imaging for prostate cancer: what’s next? Eur Urol. 2018;74(1):48–54.
   PubMed Web of Science ®Google Scholar
• Wysock JS, Mendhiratta N, Zattoni F, et al. Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results. BJU Int. 2016;118(4):515–520.
   PubMed Web of Science ®Google Scholar
• Itatani R, Namimoto T, Atsuji S, et al. Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies. Eur J Radiol. 2014;83(10):1740–1745.
   PubMed Web of Science ®Google Scholar
• Filson C, Margolis D, Huang J, et al. MP60-11 should a normal multiparametric MRI preclude prostate biopsy? J Urol. 2015;193:e742.
   Web of Science ®Google Scholar
• Moldovan PC, Van den Broeck T, Sylvester R, et al. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European association of urology prostate cancer guidelines panel. Eur Urol. 2017;72(2):250–266.
   PubMed Web of Science ®Google Scholar
• Borofsky S, George AK, Gaur S, et al. What are we missing? False-negative cancers at multiparametric MR imaging of the prostate. Radiology. 2018;286(1):186–195.
   PubMed Web of Science ®Google Scholar
• Meng X, Rosenkrantz AB, Huang R, et al. The institutional learning curve of magnetic resonance imaging-ultrasound fusion targeted prostate biopsy: temporal improvements in cancer detection in 4 years. J Urol. 2018;200(5):1022–1029.
   PubMed Web of Science ®Google Scholar
• Calio B, Sidana A, Sugano D, et al. Changes in prostate cancer detection rate of MRI-TRUS fusion vs systematic biopsy over time: evidence of a learning curve. Prostate Cancer Prostatic Dis. 2017;20(4):436–441.
   PubMed Web of Science ®Google Scholar
• Stabile A, Dell’Oglio P, Gandaglia G, et al. Not all multiparametric magnetic resonance imaging-targeted biopsies are equal: the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer. Eur Urol Oncol. 2018;1(2):120–128.
   PubMed Web of Science ®Google Scholar
• Greer MD, Brown AM, Shih JH, et al. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study. J Magn Reson Imaging. 2017;45(2):579–585.
   PubMed Web of Science ®Google Scholar
• Muller S, Lilleaasen G, Sand TE, et al. Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA. World J Urol. 2018;36(5):687–691.
   PubMed Web of Science ®Google Scholar
• Esses SJ, Taneja SS, Rosenkrantz AB. Imaging facilities’ adherence to PI-RADS v2 minimum technical standards for the performance of prostate MRI. Acad Radiol. 2018;25(2):188–195.
   PubMed Web of Science ®Google Scholar
• Rosenkrantz AB, Ayoola A, Hoffman D, et al. The learning curve in prostate MRI interpretation: self-directed learning versus continual reader feedback. AJR Am J Roentgenol. 2017;208(3):W92–w100.
   PubMed Web of Science ®Google Scholar
• Rosenkrantz AB, Begovic J, Pires A, et al. Online interactive case-based instruction in prostate magnetic resonance imaging interpretation using prostate imaging and reporting data system version 2: effect for novice readers. Curr Probl Diagn Radiol. 2019;48(2):132–141.
   PubMed Web of Science ®Google Scholar
• Kasivisvanathan V, Ambrosi A, Giganti F, et al. A dedicated prostate MRI teaching course improves the ability of the urologist to interpret clinically significant prostate cancer on multiparametric MRI. Eur Urol. 2019;75(1):203–204.
   PubMed Web of Science ®Google Scholar
• Greer MD, Lay N, Shih JH, et al. Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader study. Eur Radiol. 2018;28(10):4407–4417.
   PubMed Web of Science ®Google Scholar
• Hambrock T, Vos PC, Hulsbergen–van de Kaa CA, et al. Prostate cancer: computer-aided diagnosis with multiparametric 3-T MR imaging—effect on observer performance. Radiology. 2013;266(2):521–530.
   PubMed Web of Science ®Google Scholar
• Niaf E, Rouvière O, Mège-Lechevallier F, et al. Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI. Phys Med Biol. 2012;57(12):3833–3851.
   PubMed Web of Science ®Google Scholar
• Armato SG 3rd, Huisman H, Drukker K, et al. PROSTATEx challenges for computerized classification of prostate lesions from multiparametric magnetic resonance images. J Med Imaging (Bellingham). 2018;5(4):044501.
   PubMedGoogle Scholar
• Woo S, Suh CH, Kim SY, et al. Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis. Eur Urol. 2017;72(2):177–188.
   PubMed Web of Science ®Google Scholar
• Lay N, Tsehay Y, Greer MD, et al. Detection of prostate cancer in multiparametric MRI using random forest with instance weighting. J Med Imaging (Bellingham). 2017;4(2):024506.
   PubMedGoogle Scholar
• Wang S, Burtt K, Turkbey B, et al. Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research. Biomed Res Int. 2014;2014:789561.
   PubMed Web of Science ®Google Scholar
• Song Y, Zhang Y-D, Yan X, et al. Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI. J Magn Reson Imaging. 2018;48(6):1570–1577.
   PubMed Web of Science ®Google Scholar
• Giannini V, Mazzetti S, Armando E, et al. Multiparametric magnetic resonance imaging of the prostate with computer-aided detection: experienced observer performance study. Eur Radiol. 2017;27(10):4200–4208.
   PubMed Web of Science ®Google Scholar
• Gaur S, Lay N, Harmon SA, et al. Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? A multi-center, multi-reader investigation. Oncotarget. 2018;9(73):33804.
   PubMedGoogle Scholar
• Padhani AR, Turkbey B. Detecting prostate cancer with deep learning for MRI: a small step forward. Radiology. 2019;293(3):618–619.
   PubMed Web of Science ®Google Scholar